We are live on ! Find out more
BLU

BELLUS Health Inc.

Delisted

BLU was delisted on the 28th of June, 2023.

46 hedge funds and large institutions have $137M invested in BELLUS Health Inc. in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more capital invested

Capital invested by funds: $52.8M → $137M (+$84.6M)

86% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 7

8% less funds holding

Funds holding: 5046 (-4)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

Holders
46
Holders Change
-4
Holders Change %
-8%
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
13
Reduced
7
Closed
19
Calls
Puts
Net Calls
Net Calls Change

BLU Hedge Fund Activity: Q4 2020 in Review

46 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q4 2020, worth a combined $137M — up 160% from $52.8M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of BLU and 16 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 13 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $16.9M. The largest seller was OrbiMed, cutting an estimated $2.57M.

  • 46 institutional investors held BELLUS Health Inc. (BLU) as of Q4 2020, down from 50 in Q3 2020.
  • Funds reported $137M of BELLUS Health Inc. stock for Q4 2020, up 160% quarter-over-quarter.
  • 16 funds opened new BELLUS Health Inc. positions in Q4 2020 and 19 closed out, a net change of -3 holders.
  • The largest BELLUS Health Inc. buyer in Q4 2020 was Point72 Asset Management, an estimated $16.9M added.
  • The largest BELLUS Health Inc. seller in Q4 2020 was OrbiMed, an estimated $2.57M sold.

Based on aggregated 13F filings for Q4 2020.